Thermalin Diabetes Secures $3,142,094 Series B Funding Round

  • Feed Type
  • Date
    7/16/2013
  • Company Name
    Thermalin Diabetes
  • Mailing Address
    10000 Cedar Avenue 2nd Floor Cleveland , OH 44106
  • Company Description
    Thermalin Diabetes Inc. is developing a portfolio of insulin analogs to address both the fast-acting and long-acting insulin markets.
  • Website
    http://www.thermalin.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,142,094
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.